NextCure (NXTC) Current Assets (2018 - 2026)
NextCure (NXTC) posted quarterly Current Assets of $31.7 million for Q1 2026, down 46.11% year-over-year from $58.9 million in Q1 2025, and down 27.44% quarter-over-quarter from $43.7 million in Q4 2025.
NextCure (NXTC) Current Assets (2018 - 2026) Analysis & Trends
NextCure's Current Assets history runs 9 years deep, the most recent figure standing at $31.7 million for Q1 2026.
- In Q1 2026, Current Assets fell 46.11% year-over-year to $31.7 million; the TTM figure through Mar 2026 stood at $31.7 million (down 46.11% YoY), while the FY2025 annual figure was $43.7 million, down 39.08% from the prior year.
- Current Assets for Q1 2026 stood at $31.7 million, down from $43.7 million in the prior quarter.
- The five-year high for Current Assets was $208.9 million in Q1 2022, with the low at $31.7 million in Q1 2026.
- The 5-year median for Current Assets is $102.6 million (2024), against an average of $106.6 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets slipped 23.48% in 2022, then sank 58.52% in 2025.
- NextCure's Current Assets stood at $164.0 million in 2022, then sank by 31.26% to $112.7 million in 2023, then plunged by 36.3% to $71.8 million in 2024, then tumbled by 39.08% to $43.7 million in 2025, then decreased by 27.44% to $31.7 million in 2026.
- Business Quant data shows NXTC's Current Assets at $31.7 million in Q1 2026, $43.7 million in Q4 2025, and $32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | 22.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.26 Mn |
| Mar 31, 2026 | 31.74 Mn |
| Dec 31, 2025 | 43.75 Mn |
| Sep 30, 2025 | 32.64 Mn |
| Jun 30, 2025 | 40.02 Mn |
| Mar 31, 2025 | 58.90 Mn |
| Dec 31, 2024 | 71.81 Mn |
| Sep 30, 2024 | 78.69 Mn |
| Jun 30, 2024 | 90.46 Mn |
| Mar 31, 2024 | 102.55 Mn |
| Dec 31, 2023 | 112.73 Mn |
| Sep 30, 2023 | 122.68 Mn |
| Jun 30, 2023 | 135.30 Mn |
| Mar 31, 2023 | 148.92 Mn |
| Dec 31, 2022 | 163.98 Mn |
| Sep 30, 2022 | 175.32 Mn |
| Jun 30, 2022 | 192.95 Mn |
| Mar 31, 2022 | 208.93 Mn |
| Dec 31, 2021 | 227.82 Mn |
| Sep 30, 2021 | 243.04 Mn |